Oruka Therapeutics, Inc. Operating Leases, Future Minimum Payments, Due in Two Years
Oruka Therapeutics, Inc. (ORKA) had Operating Leases, Future Minimum Payments, Due in Two Years of $83.00 thousand as of 2018-09-30, per its 10-Q filed 2018-11-14.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears · last filed 2018-11-14
- 2018-09-30: Operating Leases, Future Minimum Payments, Due in Two Years $83.00K.
- 2018-06-30: Operating Leases, Future Minimum Payments, Due in Two Years $83.00K.
- 2018-03-31: Operating Leases, Future Minimum Payments, Due in Two Years $83.00K.
- 2017-12-31: Operating Leases, Future Minimum Payments, Due in Two Years $83.00K.
| Period end | Operating Leases, Future Minimum Payments, Due in Two Years |
|---|---|
| 2018-09-30 | $83.00K 10-Q · filed 2018-11-14 |
| 2018-06-30 | $83.00K 10-Q · filed 2018-08-09 |
| 2018-03-31 | $83.00K 10-Q · filed 2018-05-08 |
| 2017-12-31 | $83.00K 10-K · filed 2018-03-22 |
| 2017-09-30 | $88.00K 10-Q · filed 2017-11-09 |
| 2017-06-30 | $88.00K 10-Q · filed 2017-08-03 |
| 2017-03-31 | $88.00K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $88.00K 10-K · filed 2017-03-21 |
| 2016-09-30 | $83.00K 10-Q · filed 2016-11-14 |
| 2016-06-30 | $83.00K 10-Q · filed 2016-08-09 |
| 2016-03-31 | $83.00K 10-Q · filed 2016-05-11 |
| 2015-09-30 | $62.00K 10-Q · filed 2015-11-12 |
| 2015-06-30 | $62.00K 10-Q · filed 2015-08-11 |
| 2015-03-31 | $62.00K 10-Q · filed 2015-05-12 |
| 2014-12-31 | $62.00K 10-K · filed 2015-03-19 |
| 2014-09-30 | $62.00K 10-Q · filed 2014-11-12 |
| 2014-06-30 | $62.00K 10-Q · filed 2014-08-13 |
| 2014-03-31 | $62.00K 10-Q · filed 2014-05-13 |
| 2013-12-31 | $80.00K 10-K · filed 2014-03-20 |
| 2013-09-30 | $78.00K 10-Q · filed 2013-11-13 |
| 2012-09-30 | $40.00K 10-Q · filed 2012-11-13 |
| 2012-06-30 | $40.00K 10-Q · filed 2012-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Veradermics, Inc (MANE) | United States | $4.839B |